The main objective of the proposed research is to study the molecular events associated with the life-cycle of the human pathogenic parvovirus B19 believed to be the etiologic agent for several human diseases such as erythema infectiosum, transient aplastic crisis associated with several types of hemolytic anemias including sickle cell disease, post-infection anthropathy and possibly hydrops fetalis. In view of the clinical importance of B19, cellular and molecular biology of this parvovirus will be studied as follows: 1. The target cell in the erythroid lineage of human bone marrow cells for the B19 infection will be further characterized by isolating highly enriched hematopoietic progenitor cells by sorting with monoclonal antibodies recognized by human progenitor cells. Production of high-titer B19 progeny virus in this cell culture system will facilitate further studies on the virus-host cell interactions, and the molecular events throughout the course of the viral infection. 2. A generalized transcription map of the B19 viral genome will be constructed by characterizing all the major promoters and the viral RNA transcripts including mapping of the 5' - and 3' -termini and the splice-sites n the RNA transcripts. 3. The structural analysis of the termini of the viral DNA and its replicative intermediates will be carried out to elucidate the underlying mechanism of the viral DNA replication. The possibility of the involvement of a putative protein in the resolution and replication of the viral hairpin DNA termini will also be explored. These studies are aimed at gaining an insight into the molecular basis of the B19 viral pathogenesis in humans. The long-term objectives of these studies are to unravel some of the intricacies of the cellular and molecular interactions of the B19 parvovirus with, and its remarkable specificity for, the hematopoietic cells of erythroid lineage.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
1R29AI026323-01
Application #
3454674
Study Section
Experimental Virology Study Section (EVR)
Project Start
1988-05-01
Project End
1993-04-30
Budget Start
1988-05-01
Budget End
1989-04-30
Support Year
1
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Type
Schools of Medicine
DUNS #
005436803
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Ponnazhagan, S; Erikson, D; Kearns, W G et al. (1997) Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells. Hum Gene Ther 8:275-84
Kube, D M; Ponnazhagan, S; Srivastava, A (1997) Encapsidation of adeno-associated virus type 2 Rep proteins in wild-type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells. J Virol 71:7361-71
Ponnazhagan, S; Wang, X S; Woody, M J et al. (1996) Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megakaryocytic leukaemia cells are non-permissive for AAV infection. J Gen Virol 77 ( Pt 6):1111-22
Zhou, S Z; Li, Q; Stamatoyannopoulos, G et al. (1996) Adeno-associated virus 2-mediated transduction and erythroid cell-specific expression of a human beta-globin gene. Gene Ther 3:223-9
Srivastava, A; Wang, X S; Ponnazhagan, S et al. (1996) Adeno-associated virus 2-mediated transduction and erythroid lineage-specific expression in human hematopoietic progenitor cells. Curr Top Microbiol Immunol 218:93-117
Wang, X S; Yoder, M C; Zhou, S Z et al. (1995) Parvovirus B19 promoter at map unit 6 confers autonomous replication competence and erythroid specificity to adeno-associated virus 2 in primary human hematopoietic progenitor cells. Proc Natl Acad Sci U S A 92:12416-20
Ponnazhagan, S; Woody, M J; Wang, X S et al. (1995) Transcriptional transactivation of parvovirus B19 promoters in nonpermissive human cells by adenovirus type 2. J Virol 69:8096-101
Luo, F; Zhou, S Z; Cooper, S et al. (1995) Adeno-associated virus 2-mediated gene transfer and functional expression of the human granulocyte-macrophage colony-stimulating factor. Exp Hematol 23:1261-7
Zhou, S Z; Cooper, S; Kang, L Y et al. (1994) Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood. J Exp Med 179:1867-75
Ponnazhagan, S; Nallari, M L; Srivastava, A (1994) Suppression of human alpha-globin gene expression mediated by the recombinant adeno-associated virus 2-based antisense vectors. J Exp Med 179:733-8

Showing the most recent 10 out of 19 publications